The risk of tuberculosis was lower in etanercept users than in users of monoclonal antibody forms of TNF inhibitors in Asia [105], which may arise from the relatively low affinity of etanercept for TNF-α compared with the monoclonal antibody forms of TNF inhibitors [38]. The gene discussed is TNF; the disease is tuberculosis.